Search Within

Anas Younes

Formats
  1. Meeting Abstract (153)
  2. Journal Article (136)
  3. Book Section (13)
  4. Book Whole (4)
  5. Editorial (4)
  6. Review (4)
  7. Conference Paper (2)
  8. Research Letter (2)
  9. Correspondence (1)
  10. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (320)
  2. Department of Medicine (320)
  3. Executive Committee, Center for Hematologic Malignancies (320)
  4. Hematologic Malignancies, Division of (320)
  5. Lymphoma (320)
  6. Hematology-Oncology Fellows (98)

More Groups

People
  1. Andrew Zelenetz (89)
  2. Connie Batlevi (81)
  3. David Straus (74)
  4. Matthew Matasar (68)
  5. Anita Kumar (67)
  6. Paul Hamlin (67)

More People

Years
  1. 2024 (3)
  2. 2023 (7)
  3. 2022 (11)
  4. 2021 (13)
  5. 2020 (26)
  6. 2019 (53)

More Years

Publications
  1. Blood (91)
  2. Journal of Clinical Oncology (25)
  3. Hematological Oncology (22)
  4. Haematologica (16)
  5. British Journal of Haematology (13)
  6. Cancer Research (10)

More Publications

Publishers
  1. American Society of Hematology (99)
  2. American Society of Clinical Oncology (27)
  3. Wiley Blackwell (25)
  4. Nature Publishing Group (19)
  5. Springer (17)
  6. American Association for Cancer Research (16)

More Publishers

Results (320)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • From empiric to mechanism-based therapy for peripheral T cell lymphoma
    Journal Article

    Intlekofer, A. M.; Younes, A.
    International Journal of Hematology (2014)

    Fulltext@MSK | Save
  • Diffuse large B-cell lymphoma: Changing treatment paradigms - The Dunleavy/Wilson article reviewed [Appropriate management of molecular subtypes of diffuse large B-cell lymphoma]
    Journal Article

    Batlevi, C. L.; Younes, A.
    Oncology (Norwalk) (2014)

    Fulltext@MSK | Save
  • Genetic landscape of diffuse large B-cell lymphoma (DLBCL) using a novel diagnostic targeted sequencing platform
    Meeting Abstract

    Setoodeh, R.; Teruya-Feldstein, J.; Seshan, V.; Levine, R.; Zelenetz, A.; Palomba, L.; Moskowitz, C.; Van Den Brink, M.; Knapp, K.; Copeland, A.; more...
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Genetic landscape of diffuse large B-cell lymphoma (DLBCL) using a novel diagnostic targeted sequencing platform
    Meeting Abstract

    Setoodeh, I.; Teruya-Feldstein, J.; Seshan, V.; Levine, R.; Zelenetz, A.; Palomba, L.; Moskowitz, C.; Van Den Brink, M.; Knapp, K.; Copeland, A.; more...
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • Reduced-intensity conditioning and allogeneic stem cell transplantation for relapsed/refractory Hodgkin lymphoma in the brentuximab vedotin era
    Meeting Abstract

    Anderlini, P.; Saliba, R.; Ledesma, C.; Chancoco, C. M.; Alexander, T. R.; Alousi, A. M.; Hosing, C.; Khouri, I. F.; Nieto, Y.; Popat, U. R.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • A novel immunomodulatory and molecularly targeted strategy for refractory Hodgkin's lymphoma
    Journal Article

    Subbiah, V.; Brown, R. E.; McGuire, M. F.; Buryanek, J.; Janku, F.; Younes, A.; Hong, D.
    Oncotarget (2014)

    Fulltext@MSK | Save
  • Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma
    Journal Article

    Fanale, M.; Assouline, S.; Kuruvilla, J.; Solal-Céligny, P.; Heo, D. S.; Verhoef, G.; Corradini, P.; Abramson, J. S.; Offner, F.; Engert, A.; more...
    British Journal of Haematology (2014)

    Fulltext@MSK | Save
  • Brentuximab vedotin for the treatment of patients with hodgkin lymphoma
    Journal Article

    Younes, A.
    Hematology/Oncology Clinics of North America (2014)

    Fulltext@MSK | Save
  • A phase I study of ISIS 481464 (AZD9150), a first-in-human, first-in-class, antisense oligonucleotide inhibitor of STAT3, in patients with advanced cancers
    Meeting Abstract

    Hong, D. S.; Younes, A.; Fayad, L.; Fowler, N. H.; Hagemeister, F. B.; Mistry, R.; Nemunaitis, J. J.; Borad, M. J.; Bryce, A. H.; Yamashita, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A first-in-man phase 1 study of CUDC-907, a first-in-class chemically-designed dual inhibitor of PI3K and HDAC in patients with refractory or relapsed lymphoma and multiple myeloma
    Meeting Abstract

    Younes, A.; Flinn, I. W.; Oki, Y.; Copland, A.; Fattaey, A.; Lai, C. J.; Laliberte, R.; Voi, M.; Berdeja, J. G.
    Blood (2013)

    Fulltext@MSK | Save